Volume 35, Issue 2 (May 2024)
Studies in Medical Sciences 2024, 35(2): 145-152 |
Back to browse issues page
Ethics code: IR.UMSU.REC.1401.232
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Rasouli J, Mousavi S J, Nazari H, Monazzami F. COMPARISON OF THE OUTCOME OF PATIENTS WITH REINFECTION AND PRIMARY INFECTION OF COVID-19 AND ITS INFLUENCING FACTORS IN WEST AZERBAIJAN PROVINCE. Studies in Medical Sciences 2024; 35 (2) :145-152
URL: http://umj.umsu.ac.ir/article-1-6229-en.html
URL: http://umj.umsu.ac.ir/article-1-6229-en.html
Master's student in Epidemiology, Urmia University of Medical Sciences, Urmia, Iran (Corresponding Author) , monazzami.f@umsu.ac.ir
Abstract: (106 Views)
Background & Aim: The COVID-19 pandemic has raised concerns about the possibility of reinfection, which could undermine global efforts to control the spread of the virus. Various factors are effective in the occurrence of re-infection of Covid-19 and studies have published different results in this regard. Therefore, the present study has been conducted in this direction and to compare the outcome of patients with re-infection & primary infection of COVID-19 and influencing factors.
Materials & Methods: The present study was conducted as a retrospective cohort. All the patients from the beginning of the epidemic until the End of June 2021, who were registered in the system of registering cases of COVID-19 in this province, were extracted. And finally, 18,401 patients with primary and recurrent infections were included in the study.
Results: The results showed that women were more likely to get re-infection. It was also found that the age groups of 18-59 years and 0-4 years had the highest percentage of infections in patients with primary and reinfections, respectively. On the other hand, there is a significant relationship between people with primary infection and re-infection in terms of having a history of heart disease, kidney disease, and high blood pressure.
Conclusion: The results of this study showed that there is a statistically significant difference between the two groups of patients with primary infection and reinfection in terms of demographic variables, some risk factors, and clinical symptoms.
Materials & Methods: The present study was conducted as a retrospective cohort. All the patients from the beginning of the epidemic until the End of June 2021, who were registered in the system of registering cases of COVID-19 in this province, were extracted. And finally, 18,401 patients with primary and recurrent infections were included in the study.
Results: The results showed that women were more likely to get re-infection. It was also found that the age groups of 18-59 years and 0-4 years had the highest percentage of infections in patients with primary and reinfections, respectively. On the other hand, there is a significant relationship between people with primary infection and re-infection in terms of having a history of heart disease, kidney disease, and high blood pressure.
Conclusion: The results of this study showed that there is a statistically significant difference between the two groups of patients with primary infection and reinfection in terms of demographic variables, some risk factors, and clinical symptoms.
Type of Study: Research |
Subject:
Epidemiology
References
1. Worldometer - real time world statistics Worldometer. [cited 2024 Jun 11]. https://www.worldometers.info/. [URL]
2. COVID-19 cases datadot. [cited 2024 Jun 11]. https://covid19.who.int/. [URL]
3. Organization WH. World health statistics 2022: monitoring health for the SDGs, sustainable development goals. 2022. [URL]
4. Islam MZ, Riaz BK, Akbar Ashrafi SA, Farjana S, Efa SS, Khan MA. Severity of COVID-19 reinfection and associated risk factors: findings of a cross-sectional study in Bangladesh bioRxiv 2022. http://dx.doi.org/10.1101/2021.12.26.21268408 [DOI:10.1101/2021.12.26.21268408]
5. Comelli A, Viero G, Bettini G, Nobili A, Tettamanti M, Galbussera AA, et al. Patient-reported symptoms and sequelae 12 months after COVID-19 in hospitalized adults: A multicenter long-term follow-up study. Front Med (Lausanne) 2022;9:834354. http://dx.doi.org/10.3389/fmed.2022.834354 [DOI:10.3389/fmed.2022.834354] [PMID] []
6. Jain VK, Iyengar K, Garg R, Vaishya R. Elucidating reasons of COVID-19 re-infection and its management strategies. Diabetes Metab Syndr 2021;15(3):1001-6. http://dx.doi.org/10.1016/j.dsx.2021.05.008 [DOI:10.1016/j.dsx.2021.05.008] [PMID] []
7. Azam M, Pribadi FS, Rahadian A, Saefurrohim MZ, Dharmawan Y, Fibriana AI. Incidence of COVID-19 reinfection: an analysis of outpatient-based data in the United States of America. medRxiv. 2021. [DOI:10.1101/2021.12.07.21267206]
8. Stokel-Walker C. What we know about covid-19 reinfection so far. BMJ 2021;372:n99. http://dx.doi.org/10.1136/bmj.n99 [DOI:10.1136/bmj.n99] [PMID]
9. Rivelli A, Fitzpatrick V, Blair C, Copeland K, Richards J. Incidence of COVID-19 reinfection among Midwestern healthcare employees. PLoS One 2022;17(1):e0262164. http://dx.doi.org/10.1371/journal.pone.0262164 [DOI:10.1371/journal.pone.0262164] [PMID] []
10. Shaheen NA, Sambas R, Alenezi M, Alharbi NK, Aldibasi O, Bosaeed M. COVID-19 reinfection: A multicenter retrospective study in Saudi Arabia. Ann Thorac Med 2022;17(2):81-6. http://dx.doi.org/10.4103/atm.atm_74_22 [DOI:10.4103/atm.atm_74_22] [PMID] []
11. Sotoodeh Ghorbani S, Taherpour N, Bayat S, Ghajari H, Mohseni P, Hashemi Nazari SS. Epidemiologic characteristics of cases with reinfection, recurrence, and hospital readmission due to COVID-19: A systematic review and meta-analysis. J Med Virol 2022;94(1):44-53. http://dx.doi.org/10.1002/jmv.27281 [DOI:10.1002/jmv.27281] [PMID] []
12. Zheng J, Zhou R, Chen F, Tang G, Wu K, Li F, et al. Correction: Incidence, clinical course and risk factor for recurrent PCR positivity in discharged COVID-19 patients in Guangzhou, China: A prospective cohort study. PLoS Negl Trop Dis 2021;15(12):e0010032. http://dx.doi.org/10.1371/journal.pntd.0010032 [DOI:10.1371/journal.pntd.0010032] [PMID] []
13. Tavakoli A, Lotfi F, Lotfi M, Bayati M, Seif M, Salesi M, et al. COVID-19 reinfection rate and related risk factors in Fars province, Iran: A retrospective cohort study. Iran J Med Sci 2023;48(3):302-12. http://dx.doi.org/10.30476/IJMS.2022.94615.2598 [PMID]
Send email to the article author
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
